Navigation Links
Incarceration, marijuana use and suicide attempts may hinder liver transplant eligibility
Date:4/4/2013

Results from an anonymous survey of U.S. transplant providers report that incarceration, marijuana use, and psychiatric diagnoses, particularly suicide attempts, may lower patients' eligibility for liver transplantation. The study published in the April issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, also found that most providers would not offer transplants to patients with advanced age, those severely obese, or with lifetime imprisonment.

"For patients with end-stage liver disease, transplantation is the only treatment option to extend life," explains lead investigator Dr. Josh Levitsky from Northwestern University Feinberg School of Medicine in Chicago, Ill. "With donated livers in such short supply, selecting candidates becomes an ethical exercise for transplant specialists who must balance equal access to transplantation with graft and patient survival."

Currently, the model for end-stage liver disease (MELD) is used to measure the severity of liver disease. The MELD score provides transplant providers with standardized criteria to allocate donated livers. However, the authors point out that subjective assessment of the candidates' medical and psychosocial characteristics could influence the providers' selection process. Medical evidence shows that controversial characteristics such as alcohol abuse, HIV status, obesity, or advanced age may impact allocation, leading to an inequity among patients being waitlisted.

To further understand the ethics involved in selecting transplant candidates, Dr. Levitsky and colleagues sent an online survey to hepatologists, surgeons, psychiatrists and social workers at 102 liver transplant centers across the U.S. Responses were received from 251 providers who answered questions regarding their opinions of characteristics that could prevent patients from receiving a liver transplant.

The majority of responders were male (71%), between 41 and 60 years of age (68%) and mainly white (77%). The three characteristics ranked most controversial were incarceration, marijuana use, and psychiatric diagnoses. Responses from transplant providers indicate that 63% would not waitlist patients 80 years or older, 57% would not transplant patients with a body mass index (BMI) greater than 45 kg/m2, and 55% specified incarceration with lifetime sentence a contraindication to liver transplantation.

Furthermore, less than half of the providers reported their centers had written policies regarding controversial characteristics that would prevent some patients from receiving liver transplants. "We found significant variation in provider opinions of criteria that are contraindications for liver transplantation, which may be why many centers do not have formal policies for selecting candidates with questionable characteristics," concludes Dr. Levitsky. "Standardized eligibility criteria, supported by evidence-based data of outcomes, are necessary to develop formal policies for selecting controversial candidates for liver transplantation."


'/>"/>

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley
Source:Eurekalert

Related medicine news :

1. MedMar Healing Center, Taking Clone Pre-Orders for High-Quality Medical Marijuana Strains
2. New Merchant Solution Provides Credibility to Medical Marijuana Industry
3. Marijuana Doctors Announces Additions to Growing Roster of Doctors
4. Marijuana Businesses No Longer Blacklisted From Marketing
5. Innovative Medical Marijuana Growing Product added to PotLocator.com Lineup
6. Massachusetts Medical Marijuana Caregivers Wanted To Partner With Compassionate Caregivers Of Massachusetts
7. Medical Marijuana: Voodoo or Legitimate Therapeutic Choice?
8. Recent marijuana use in HIV-infected Russians associated with increased sex and drug risk behaviors
9. Synthetic Marijuana Use Linked to Kidney Damage
10. New Association Created to Advocate for Medical Marijuana Patients, Dispensary Operators and Advocates
11. Prescription Painkillers Trail Only Marijuana in Abuse Rates, Report Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , ... March 29, 2017 , ... In the United ... 300,000 people each year develop other types of metastatic brain tumors(3). Though most meningiomas ... brain(3). As efforts focus on finding more effective treatment options, the San Diego ...
(Date:3/29/2017)... ... 2017 , ... Full Contact K9, an Atlanta-based dog services provider, has recently ... assists dog owners in creating legally-enforceable pet trusts for their canine companions. , ... to protect their new companion. Says Evan Dunbar, CEO of Full Contact K9, “When ...
(Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES MERCY MEDICAL ... that Mercy Medical Center will serve as the official title sponsor of the Baltimore ... June 25, 2017, thousands of women will walk or run the course around the ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, ... or "Wonder Spice", it has been used for thousands of years. , "The West ... Heshelow, author of " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... hosting several educational opportunities for attending prescribers at the upcoming World Congress, in ... said, “A4M has always been recognized as the visionary leader in the training ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017  The Global Health Innovative Technology Fund ... to battle infectious diseases around the globe, today ... could help deliver a range of new innovative ... This latest round of targeted support ... testing a pediatric formulation of a drug considered ...
(Date:3/29/2017)... -- The leader in accelerated orthodontics, OrthoAccel ® Technologies, ... Manal Ibrahim , Kenji Ojima , ... featured microlecture presenters at the AcceleDent ® booth ... Annual Session, April 21-25, 2017. Orthodontists and their staff ... 11:20 a.m. On the opening morning of AAO exhibitions, ...
(Date:3/29/2017)... 2017 Transparency Market Research ... an exhaustive study of the U.S. substance abuse treatment ... are functional in this market at present, making ... companies, such as GlaxoSmithKline Plc., Pfizer Inc., Alkermes ... various marketing strategies to increase their visibility, the ...
Breaking Medicine Technology: